What Is IGF-1 LR3?
IGF-1 LR3 is an engineered version of insulin-like growth factor 1 — the anabolic hormone GH stimulates the liver to produce. Two modifications (an arginine substitution and a 13-amino-acid extension) prevent binding proteins from capturing it, extending its active half-life from minutes to about a day.
That makes it the most direct anabolic molecule on this site: instead of asking the pituitary for GH and waiting for downstream IGF-1, it *is* the downstream signal — driving nutrient uptake, protein synthesis and cell growth wherever it binds. Power and risk scale together.
What is IGF-1 LR3 studied for?
- •Muscle protein synthesis and hypertrophy research
- •Nutrient partitioning (glucose uptake into muscle)
- •Recovery and satellite-cell activation
Side effects & safety
Hypoglycemia is the acute one — IGF-1 has real insulin-like glucose effects, and injecting fasted at high doses can drop blood sugar dangerously. Chronic concerns: IGF-1's growth signal is precisely what makes cancer history an absolute contraindication.
Legal & approval status
Research chemical; no approvals. WADA-banned, and one of the compounds testing actually catches.
Typical dosing at a glance
Related peptides
Educational overview based on published research and commonly reported community protocols — not medical advice, and not an endorsement of any compound. Consult a licensed healthcare provider.